ARCHIVES

Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | November 30, 2012

Download PDF Visit The Full Archive

Related Articles

Cornell, MSKCC, Rockefeller To collaborate In $160M Basic Biological Research Program.

June 30, 2000

NCAB Supports ACS Effort To Work With Centers

March 1, 1991

ASCO Recommends Beginning Palliative Care Alongside Standard Therapy in Metastatic NSCLC

February 24, 2012

In Brief: FDA Oncology Div. Director Burke To Leave; Reed Is Branch Chief; NCAB Blasts Tobacco

November 4, 1994

BCI Budget Chief Browning To Retire

January 12, 1979

Judge Invalidates Bristol-Myers’ Claims For The Administration Of Taxol.

March 3, 2000